Glucose control with insulin results in reduction of NF‐κB‐binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes
暂无分享,去创建一个
[1] J. Suwaidi,et al. Cardiovascular Surgery, Hamad General Hospital – Hamad Medical , 2022 .
[2] J. Schneider,et al. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. , 2004, The Journal of clinical investigation.
[3] T. Lyons,et al. ‘Lipoproteins, glycoxidation and diabetic angiopathy’ , 2004, Diabetes/metabolism research and reviews.
[4] D. Lackland,et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.
[5] D. Bonnefont-Rousselot. The Role of Antioxidant Micronutrients in the Prevention of Diabetic Complications , 2004, Treatments in endocrinology.
[6] D. Lackland,et al. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. , 2003, Kidney international.
[7] E. Ritz,et al. Special characteristics of atherosclerosis in chronic renal failure. , 2003, Clinical nephrology.
[8] Michael Stumvoll,et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. , 2003, Diabetes.
[9] John M. Lachin,et al. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.
[10] Matthew D. Davis,et al. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.
[11] M. Taskinen. Diabetic dyslipidemia. , 2002, Atherosclerosis. Supplements.
[12] P. Fasching,et al. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. , 2000, Diabetes.
[13] J. Bastard,et al. Consequences of the diabetic status on the oxidant/antioxidant balance. , 2000, Diabetes & metabolism.
[14] I. West. Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[15] B. Isermann,et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. , 1999, Diabetologia.
[16] J. Baynes,et al. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.
[17] B. Isermann,et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB , 1999, Diabetologia.
[18] T. Collins,et al. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. , 1998, Current opinion in lipidology.
[19] T. Luther,et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. , 1997, Circulation.
[20] T. Luther,et al. Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells , 1997, Diabetes.
[21] D. Männel,et al. Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.
[22] E. Stadtman,et al. Protein Oxidation in Aging, Disease, and Oxidative Stress* , 1997, The Journal of Biological Chemistry.
[23] A. Schmidt,et al. Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.
[24] A. Schmidt,et al. Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products* , 1997, The Journal of Biological Chemistry.
[25] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[26] T. Luther,et al. The Dietary Pigment Curcumin Reduces Endothelial Tissue Factor Gene Expression by Inhibiting Binding of AP-1 to the DNA and Activation of NF-κB , 1997, Thrombosis and Haemostasis.
[27] R. Knuechel,et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.
[28] W. Kisiel,et al. Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue Factor (*) , 1995, The Journal of Biological Chemistry.
[29] A. Tamir,et al. Commercial dialysate inhibits TNFα mRNA expression and NF-κB DNA-binding activity in LPS-stimulated macrophages , 1995 .
[30] V. Mohan,et al. Does oxidant stress play a role in diabetic retinopathy? , 1995, Indian journal of ophthalmology.
[31] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[32] T. Collins. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[33] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.